Patent ID: 9357966
Filing Date: 2016-06-07
CPC Classification: A61B,G06F,G16H

Claim Text:
1. A drug screening device for identifying a subject with temporary neurological impairment resulting from a chemical that depresses a subject's central nervous system, the drug screening device comprising: a. a frame configured to fit flush with a face of the subject; b. a camera attached to the frame, the camera configured to focus simultaneously on at least one eye of the subject; c. a light meter configured to measure ambient light within the frame; d. a partition in the frame separating the camera from the at least one eye; e. a target display mounted to the partition displaying a still image and a subsequent animated target image to the at least one eye; f. at least one of a plurality of tactile sensors mounted to the frame configured to verify contact with the face to prevent extraneous light from entering the frame; g. a microprocessor with a data storage attached to the frame controlling the camera, receiving signals from the light meter, controlling the target display, and monitoring signals from the at least one of the plurality of tactile sensors; h. a power supply attached to the frame electrically connected to the camera, the light meter, the target display, the microprocessor and the at least one of the plurality of tactile sensors; and i. a light source attached in the frame to illuminate a pupil of the subject and wherein lumens of the light source and the target display are calibrated by the microprocessor.